(2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester is a dimeric alkaloid found as a minor constituent in Pleiocarpa nutica Benth. It forms colorless crystals from CHCl3-MeOH and exhibits strong levorotation with [α]26D 111° (c 1.93, CHCl3). The ultraviolet spectrum in MeOH has absorption maxima at 230, 263, 285, and 292 nm. Its structure has been determined through chemical analysis and spectroscopic examination, revealing a 15-(14'-eburnamy1)p1eiocarpinine configuration.
5263-34-3
Post Buying Request-
-
Basic information
- Product Name: (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester
- Synonyms: (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester;Pleiomutine
- CAS NO:5263-34-3
- Molecular Formula: C18H15ClN2OS
- Molecular Weight: 342.8425
- EINECS: N/A
- Product Categories: N/A
- Mol File: 5263-34-3.mol
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: 427.8°Cat760mmHg
- Flash Point: 212.5°C
- Appearance: /
- Density: 1.37g/cm3
- Vapor Pressure: 1.59E-07mmHg at 25°C
- Refractive Index: 1.664
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester(CAS DataBase Reference)
- NIST Chemistry Reference: (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester(5263-34-3)
- EPA Substance Registry System: (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester(5263-34-3)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 5263-34-3(Hazardous Substances Data)
5263-34-3 Suppliers
Recommended suppliersmore
5263-34-3 Usage
Uses
Used in Pharmaceutical Industry:(2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester is used as a potential pharmaceutical compound for its various biological activities. (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester's unique structure and properties make it a promising candidate for the development of new drugs targeting specific diseases.
Used in Research and Development:
In the field of research and development, (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester serves as a valuable compound for studying its chemical properties, structural characteristics, and potential applications in drug discovery. Researchers can use (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester to explore new synthetic routes, develop novel drug delivery systems, and investigate its interactions with biological targets.
Used in Natural Product Chemistry:
(2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester is utilized in the study of natural product chemistry, particularly in the investigation of alkaloids and their derivatives. (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester can provide insights into the biosynthesis, structural diversity, and biological activities of natural products, contributing to the understanding of their potential therapeutic applications.
Used in Drug Synthesis:
As a complex organic molecule, (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester can be employed in the synthesis of new drugs and drug candidates. Its unique structure and functional groups can be exploited to design and develop novel therapeutic agents with improved efficacy, selectivity, and safety profiles.
Used in Drug Delivery Systems:
Similar to gallotannin, (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester can be incorporated into drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes. Researchers can explore the use of various organic and metallic nanoparticles as carriers for (2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester, aiming to improve its overall performance in targeted drug delivery applications.
References
Kump, Schmid., Helv. Chirn. Acta, 44, 1503 (1961) Structure and partial synthesis: Thomas, Achenbach, Biemann., 1. Arner. Chern. Soc., 88, 1537 (1966)Check Digit Verification of cas no
The CAS Registry Mumber 5263-34-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,6 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.Calculate Digit Verification of CAS Registry Number 5263-34:
(6*5)+(5*2)+(4*6)+(3*3)+(2*3)+(1*4)=83
83 % 10 = 3
So 5263-34-3 is a valid CAS Registry Number.
InChI:InChI=1/C18H15ClN2OS/c1-18(2)7-13-16(14(22)8-18)15(12(9-20)17(23)21-13)10-3-5-11(19)6-4-10/h3-6H,7-8H2,1-2H3,(H,21,23)
5263-34-3Upstream product
5263-34-3Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 5263-34-3
(2β,5β,12S,19β)-15-[14,15-Dihydroeburnamenin-14α-yl]-1-methylaspidofractinine-3α-carboxylic acid methyl ester
